Tobramycin
15 NDCs across 15 manufacturers|14 Generic,1 Brand
Tobramycin is used to treat infectious bone diseases, central nervous system infections, bacterial eye infections, intraabdominal infections, pseudomonas infections and respiratory tract infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Dec 13, 1984. In 2024, Medicare Part D spent $15 million on Tobramycin across 249,000 claims for 200,000 beneficiaries.
Tobramycin is available as 15 NDCs from 15 manufacturers (14 generic, 1 brand), with NADAC prices from $0.74 to $1.16 per ML — a 57% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
15
14G / 1B
Manufacturers
15
competing in market
Price Spread
$0.74 – $1.16
per ML, 14 of 15 NDCs
7d Activity
avg +3.0% WoW · of 15 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
15 manufacturers producing TOBRAMYCIN(4 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TOBREX 0.3% EYE OINTMENT | $84.5164 per GM | +0.03% |
TOBRAMYCIN 0.3% EYE DROP | $1.1579 per ML | +3.61% |
TOBRAMYCIN 0.3% EYE DROP | $1.1579 per ML | +3.61% |
TOBRAMYCIN 0.3% EYE DROP | $1.1579 per ML | +3.61% |
TOBRAMYCIN 300 MG/5 ML AMPULE | $1.0845 per ML | -0.86% |
TOBRAMYCIN 300 MG/5 ML AMPULE | $1.0845 per ML | -0.86% |
TOBRAMYCIN 300 MG/5 ML AMPULE | $1.0845 per ML | -0.86% |
TOBRAMYCIN 300 MG/5 ML AMPULE | $1.0845 per ML | -0.86% |
TOBRAMYCIN 300 MG/5 ML AMPULE | $1.0845 per ML | -0.86% |
TOBRAMYCIN 300 MG/5 ML AMPULE | $1.0845 per ML | -0.86% |
TOBRAMYCIN 300 MG/5 ML AMPULE | $1.0845 per ML | -0.86% |
TOBRAMYCIN 300 MG/5 ML AMPULE | $1.0845 per ML | -0.86% |
TOBRAMYCIN 80 MG/2 ML VIAL | $0.7395 per ML | +13.76% |
TOBRAMYCIN 80 MG/2 ML VIAL | $0.7395 per ML | +13.76% |
TOBRAMYCIN 80 MG/2 ML VIAL | $0.7395 per ML | +13.76% |
Frequently Asked Questions
What is Tobramycin used to treat?
Tobramycin is used to treat infectious bone diseases, central nervous system infections, bacterial eye infections, intraabdominal infections, pseudomonas infections and respiratory tract infections, per the National Library of Medicine's MED-RT classification.
When did Tobramycin become available as a generic?
FDA approved the first generic Tobramycin (ANDA) on Dec 13, 1984.
How much does Medicare spend on Tobramycin?
In 2024, Medicare Part D spent $15 million on Tobramycin across 249,000 claims for 200,000 beneficiaries.
How many Tobramycin products are on the market?
The Tobramycin drug market contains 15 NDCs from 15 manufacturers — 14 generic and 1 brand product.
What is the price range for Tobramycin?
NADAC reference prices for Tobramycin range from $0.7395 to $1.1579 per ML — a 57% difference between cheapest and most expensive. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Tobramycin?
15 manufacturers list Tobramycin in NADAC. Ranked by number of NDCs, the largest are Novartis Pharmaceuticals Corporation (1), Somerset Therapeutics, LLC (1), Sandoz Inc. (1), Bausch & Lomb Incorporated (1), Ritedose Pharmaceuticals, LLC (1).
How has the price of Tobramycin changed recently?
Over the past 7 days, 7 Tobramycin NDCs rose and 8 fell, with a market-wide average change of +3.0%.